Clinical red flags which should alert the clinician to test for IgLON5 antibodies are prominent sleep disorders, in particular a non-rapid eye movement (NREM) sleep parasomnia with simple and finalistic movements, breathing difficulties (related or unrelated to sleep; stridor), cognitive decline, and bulbar symptoms [30]. Here, IGLON5 is linked to sleep disorder.